- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00801112
Bioimpedance as a Tool for Fluid Management in Peritoneal Dialysis (PD) Patients
Developing Bioimpedance (BIA) as a Tool for Fluid Management in Peritoneal Dialysis Patients: A Validation Study
Hypothesis: The investigators hypothesize that regular monitoring of BIA adds value to the management of fluid status in PD patients
Objectives of the study: The objective is to show that in patients where the additional information of body composition is available to the clinician that the ECFv is maintained within pre-agreed limits, ~ 1 liter, over the observation period of 12 months.
SCIENTIFIC BACKGROUND:
Low peritoneal ultrafiltration, and by inference low sodium removal, is associated with worse outcomes in PD. Equally, excessive fluid removal is a risk factor for dehydration and loss of residual renal function. Current guidelines have advocated a daily UF volume of 1litre; their blunt application could lead to either inappropriate early loss of residual function or modality transfer. There is a significant need for evidence on how to best manage fluid status in PD patients, both in terms of an appropriate clinical strategy and also a simple but reproducible tool to guide clinicians in how to apply this strategy.
It is likely that BIA will become the standard tool to aid clinicians in assessing fluid status. It is simple to perform, intervention studies have demonstrated its ability to identify changes in fluid status in response to changes in therapy and it is a powerful predictor of patient survival. There is, however a clear need at this stage for proof of principle studies to establish its true potential for added value in the routine management of patients.
Body composition changes spontaneously with time on PD. Short term changes in hydration (specifically extracellular fluid volume, ECFv) combined with medium term changes in muscle and fat make it difficult for the clinician to be sure if fluid status is stable. It is anticipated that regular BIA measurements will aid the clinician in managing this problem over and above monitoring of weight and fluid status. By randomizing patients into two groups who have regular BIA measurements, one of which the BIA data is available to the clinician it will be possible to see if these spontaneous changes in body composition can be accounted for.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Simon J Davies, MD FRCP
- Phone Number: +44(0)1782 554164
- Email: simondavies1@compuserve.com
Study Contact Backup
- Name: Kay B Tan, MB MRCP
- Phone Number: +44(0)1782 554185
- Email: tanbkay@doctors.org.uk
Study Locations
-
-
Staffordshire
-
Stoke on Trent, Staffordshire, United Kingdom, ST4 7LN
- University Hospital of North Staffordshire
-
Contact:
- Simon J Davies, MD FRCP
- Phone Number: +44(0)1782 554164
- Email: simondavies1@compuserve.com
-
Contact:
- Kay B Tan, MB MRCP
- Phone Number: +44(0)1782 554185
- Email: tanbkay@doctors.org.uk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All PD patients who are clinically stable
Exclusion Criteria:
- Patients planning discontinuation of PD within 6 months.
- Patients who are unable to give consent.
- Patients who have peritonitis the last 30 days prior to study enrollment.
- Patients who are pregnant.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
1
PD patients with residual renal function >200ml with BIA monitor.
|
2
PD patients with residual renal function <200ml with BIA monitor.
|
3
PD patients with residual renal function >200ml without BIA monitor
|
4
PD patients with residual renal function <200ml without BIA monitor
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Extra-cellular Fluid Volume (ECFv) determined from BIA to be maintained within pre-agreed limit of 1 liter.
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Blood pressure control and residual urine volume.
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Simon J Davies, MD FRCP, University Hospital of North Staffordshire
Study record dates
Study Major Dates
Study Start
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- BIA-001MC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peritoneal Dialysis
-
Sunnybrook Health Sciences CentreNot yet recruitingPeritoneal Dialysis Complication | Peritoneal Dialysis Access FailureCanada
-
University of Southern CaliforniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedPeritoneal Dialysis | Dialysis | Hospitalizations
-
Carmel Medical CenterRecruitingPeritoneal Dialysis Catheter Infection | Peritoneal Dialysis-associated Peritonitis | Peritoneal Dialysis ComplicationIsrael
-
Satellite HealthcareCompletedPeritoneal DialysisUnited States
-
University Hospital, Strasbourg, FranceCompleted
-
RenJi HospitalCompletedUnderstand the Association Between Peritoneal Dialysis Status and Gene Polymorphisms of VEGF and KDRPeritoneal DialysisChina
-
University Hospital, CaenCompletedPeritoneal DialysisFrance
-
University Hospital, UmeåCompleted
-
Samsung Medical CenterUnknownPeritoneal DialysisKorea, Republic of
-
First Affiliated Hospital, Sun Yat-Sen UniversityBaxter Healthcare CorporationRecruiting